Clinical Trial Update: Study of Motexafin Gadolinium for the Treatment of Non-Hodgkin's Lymphoma [Phase 2]

View source ↗

Summary

This update notes that a Phase 2 clinical trial of motexafin gadolinium for non-Hodgkin lymphoma has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-hodgkin Lymphoma

Drugs mentioned

• Motexafin Gadolinium (motexafin gadolinium)

Snippet

Sponsor: Pharmacyclics LLC. | Conditions: Lymphoma, Non-Hodgkin's Lymphoma | Phase 2 | Status: COMPLETED